Prevalence of impaired kidney function & its association with diabetes & hypertension in India: The ICMR-INDIAB study (ICMR-INDIAB-22)
- PMID: 41100657
- DOI: 10.25259/IJMR_1027_2025
Prevalence of impaired kidney function & its association with diabetes & hypertension in India: The ICMR-INDIAB study (ICMR-INDIAB-22)
Abstract
Background & objectives Chronic kidney disease remains a leading cause of morbidity and mortality in developing nations like India. This study was conducted to assess the prevalence of impaired kidney function (IKF) and its association with type 2 diabetes(T2D) and systemic hypertension (HTN) in India. Methods A total of 25,408 individuals (with/without HTN and T2D), a nationally representative sample, were included from the Indian Council of Medical Research-INdia-DIABetes (ICMR-INDIAB) cross-sectional study. IKF was defined as estimated glomerular filtration rate eGFR <60 mL/min/1.73 m2 (CKD-EPI-2009 equation-race free). Results The overall weighted prevalence of IKF was 3.2 per cent [95% confidence interval (CI): 2.9-3.5] with no significant differences between urban [3.3% (2.8-3.7)] and rural areas [3.2% (2.9-3.5)], but higher among males [3.8% (3.4-4.2)] compared to females [2.6% (2.3-2.9)]. Four States in the country had prevalence of IKF ≥6 per cent and another four States had prevalence ≥4 per cent. The decrease in eGFR for every year increase in age was around 1.0 ml/min/1.73 m2; this was greater in urban areas, females, and in those with both HTN and T2D. Presence of T2D alone was associated with significantly higher risk of IKF compared to HTN alone (Odds Ratio 3.2 vs. 2.4); however, the risk was six fold higher in individuals with both HTN and T2D. Interpretation & conclusions The burden of IKF is high across India and is likely to rise further owing to high prevalence of metabolic risk factors. T2D seems to confer higher risk of IKF compared to HTN in this population.
Keywords: Asian Indians; diabetes; hypertension; impaired kidney function; prevalence.
References
-
- GBD Chronic Kidney Disease Collaboration.Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet.2020; 395:709-33
-
- GBD 2017 Causes of Death Collaborators.Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017.Lancet.2018; 392:1736-88
-
- ThompsonA,LawrenceJ,StockbridgeN,.GFR decline as an end point in trials of CKD: a viewpoint from the FDA.Am J Kidney Dis.2014; 64:836-7
-
- ProvenzanoM,HuL,AbenavoliC,CiancioloG,CoppolinoG,De NicolaL,et al.Estimated glomerular filtration rate in observational and interventional studies in chronic kidney disease.J Nephrol.2024; 37:573-86
-
- LeveyAS,TitanSM,PoweNR,CoreshJ,InkerLA,.Kidney Disease, Race, and GFR Estimation.Clin J Am Soc Nephrol.2020; 15:1203-12
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
